An α-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes

✍ Scribed by Miwako Tsunosue; Naomi Mashiko; Yhukou Ohta; Yoshito Matsuo; Kouichi Ueda; Masayuki Ninomiya; Sho-ichi Tanaka; Masaru Hoshiko; Yasutsugu Yoshiyama; Masayoshi Takeuchi; Shin-ichiro Ueda; Sho-ichi Yamagishi

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 150 KB
• Volume: 10
• Category: Article
• ISSN: 0372-8722
• DOI: 10.1007/s10238-009-0074-9